Company / Capital Expenditures
ARVINAS, INC. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.9M
FY2025
5-year range
$1.8M / $6.4M
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#97 of 194
Health Care
What the data says
At $2M, ARVINAS, INC.'s capital expenditures ranks #97 of 194 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $2M.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -21.6%.
Declined from $3M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -33.3%
- 5-Year CAGR
- -21.6%
- 10-Year CAGR
- -
Sector benchmark
#97 of 194 in Health CareTop 50% of 194This company $1.9M Sector average $117.5M
▼
-98.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -21.6%, indicating a declining trend.
- In FY2025, capital expenditures increased 5.6% year-over-year.
- Ranks #97 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | +5.6% |
| FY2024 | $1.8M | -37.9% |
| FY2023 | $2.9M | -54.7% |
| FY2022 | $6.4M | +1.6% |
| FY2021 | $6.3M | -1.6% |
| FY2020 | $6.4M | +126.1% |
| FY2019 | $2.8M | +0.0% |
| FY2018 | $2.8M | +179.6% |
| FY2017 | $1.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026